ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 231

Impact of an Educational Program for the Management of Gout Directed to Primary Care Physicians

Sandra Chinchilla1, Irati Urionagüena1 and Fernando Perez-Ruiz1,2, 1Rheumatology Division, Hospital Universitario Cruces, Baracaldo, Spain, 2BioCruces Health Research Institute, Baracaldo, Spain

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Education, gout and primary care, medical

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Metabolic and Crystal Arthropathies - Poster I: Clinical Practice

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:  Gout is the most frequent inflammatory arthritis in males, and therefore a common cause for consultation in both primary care and specialist settings. Despite its frequency, the diagnosis and treatment for this condition are far from desirable. There is evidence of gout management improvement through educational programs targeted at primary care physicians. Objective: To measure the impact in diagnostic and therapeutic attitudes towards patients with gout, in primary care physicians, before and after performing an educational intervention based on a clinical case. 

Methods:  Through a training program aimed at general physicians with interest in musculo-skeletal diseases, an initiative of the Sociedad Española de Reumatología [Spanish Rheumatology Society] and the Sociedad Española de Médicos de Atención Primaria [Spanish Society for Primary Care Physicians], sessions were held in 6 Spanish locations. In the sessions, a general physician presented a clinical case about a patient with hyperuricaemia, intermittent arthritis, condrocalcinosis in knee joints and several associated comorbidities. In first place, 5 questions with multiple-choice answers were formulated, regarding the diagnosis and treatment deemed appropriate. Later, the case was evaluated and discussed by a rheumatologist, and the same questions were repeated. Answers were recorded by electronic means.

Results:  A total of 195 physicians, divided in 6 locations, attended the sessions. Statistically significant results for each evaluated area are summarized below: Diagnosis: initially 21.8% of the attendants deemed arthrocentesis necessary for the diagnosis, but complementary investigations appeared to be more important (67.3%). Afterwards, a significant increase in the need for arthrocentesis was observed (46.7%). Comorbidities: 52.6% of the attendants decided to prescribe a non-steroidal anti-inflammatory drug (NSAID) to the fictional patient, with chronic kidney disease. After the discussion, the broad majority of assistants opted for alternatives such as steroids (41.23%) and only 4.74% still preferred NSAIDs. Initial complexity for diagnosis: a small percentage (12.7%) considered that a solid diagnosis was not possible without a sample of synovial fluid. This percentage rose up to 55.5% after the intervention. Prophylaxis: Colchicine-based prophylaxis was prescribed initially by 57.4% of physicians, and after the session, by most of them (71.6%). Urate lowering drugs: A change was observed in the use of urate lowering medications, from an initial 64.7%, up to 85.1% after the discussion. There was a reduction in the number of referrals to specialists, but it was not statistically significant.

Conclusion: Through educational initiatives for primary care physicians it is possible to optimize the perception of diagnosis and treatment in patients with gout.


Disclosure: S. Chinchilla, None; I. Urionagüena, None; F. Perez-Ruiz, Fundación Española de Reumatología, 2,Asociación de Reumatólogos del Hospital de Cruces, 2,Menarini, 8,AstraZeneca, 8,AstraZeneca, 5,Menarini, 5.

To cite this abstract in AMA style:

Chinchilla S, Urionagüena I, Perez-Ruiz F. Impact of an Educational Program for the Management of Gout Directed to Primary Care Physicians [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/impact-of-an-educational-program-for-the-management-of-gout-directed-to-primary-care-physicians/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-an-educational-program-for-the-management-of-gout-directed-to-primary-care-physicians/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology